The world is changing
The IDL A101 PoCT Diagnostic Analyser brings point-of-care to the high street.
2025 - A year when IDL changes the face of high street diagnostics
2024: The Year IDL Revolutionizes High Street Diagnostics
In 2025, Imperial Diagnostix is set to transform the landscape of high street diagnostics. Over the past year, we have secured three valuable partnerships with leading manufacturers, positioning IDL as a major player in the In Vitro, Fluorescence, and Immunoassay Diagnostics sectors of the healthcare industry.
At the heart of our offering a cutting-edge analyser, designed for a distinct role in PoCT diagnostics:
The IDL 101 Analyzer
This point-of-care analyzer competes with traditional pathology testing by utilizing whole blood, serum, plasma, urine, and fecal samples. With its more sensitive testing capabilities, the IDL 101 diagnoses up to 67 conditions in key areas such as:
- Cardiac health
- Inflammation
- Fertility
- Diabetes (HbA1C and Insulin)
- Liver and renal function
- Cancer markers
- Infectious diseases
IDL offers these
products individually or as part of the Lab Case, which enables frontline healthcare professionals to perform diagnostics at a pathology lab standard.
The IDL 101
The IDL 101 is a highly versatile POCT analyser with a highly sensitive and accurate portfolio of tests as seen above. The 101 has a 10 hour battery life and 67 tests giving results in 15 minutes. Particularly effective in remote areas, war zones (Ukraine), South African townships and Australian flying doctors